Abstract: Compounds that promote growth hormone releasing activity are disclosed. These compounds have the formula: A1-A2-X; A1?-X?; or A1?-Y These compounds can be present in a pharmaceutical composition. The compounds can be used with a second compound that acts as an agonist at the growth hormone releasing hormone receptor or which inhibits the effects of somatostatin. These compounds can be used for a variety of uses such as treating hypothalamic pituitary dwarfism, osteoporosis, burns, or promoting wound healing.

Abstract: Compounds that promote growth hormone releasing activity are disclosed. These compounds have the formula: A1-A2-X; Al1′-X′; or A1″-Y These compounds can be present in a pharmaceutical composition. The compounds can be used with a second compound that acts as an agonist at the growth hormone releasing hormone receptor or which inhibits the effects of somatostatin. These compounds can be used for a variety of uses such as treating hypothalamic pituitary dwarfism, osteoporosis, burns, or promoting wound healing.

Abstract: Compounds that promote growth hormone releasing activity are disclosed.

Abstract: Disclosed are novel polypeptide compounds which promote the release and elevation of growth hormone levels in the blood of animals. Also disclosed are methods of promoting the release and elevation of growth hormone levels in the blood of animals using the disclosed polypeptide compounds.

Abstract: Novel polypeptides which promote the release of growth hormone when administered to animals are described. These polypeptides have the formula:A.sub.1 --D.sup..beta. Nal--A.sub.3 --Trp--A.sub.5 --A.sub.6 --Zwherein A.sub.1, A.sub.3, A.sub.5, A.sub.6 and Z" are as defined in the specification.

Abstract: Disclosed are novel polypeptides selected from the group consisting of: ##STR1## functional equivalents thereof: and organic and inorganic addition salts thereof; and ##STR2## functional equivalents thereof:and organic and inorganic addition salts thereof.These polypeptides have been found to promote the release and elevation of growth hormone levels in the blood of animals. Also disclosed are novel combinations of said polypeptides with other polypeptides, novel formulations including said polypeptides as well as methods for administering said polypeptides, alone and in combination with other polypeptides acting in a synergistic manner to promote release and elevation of growth hormone levels in animals.

Abstract: Disclosed are combinations of polypeptides acting in a synergistic manner to promote release and elevation of growth hormone levels in the blood of animals. Also disclosed are methods of promoting the release and elevation of growth hormone levels in the blood of animals using the disclosed combination of polypeptides.

Abstract: Disclosed are novel polypeptide compounds which promote the release and elevation of growth hormone levels in the blood of animals. Also disclosed are methods of promoting the release and elevation of growth hormone levels in the blood of animals using the disclosed polypeptide compounds.

Abstract: Novel peptides having the following amino acid sequence ##STR1## wherein X.sub.1, X.sub.2, and X.sub.3 are selected from a group consisting of N-terminal and desamino alpha-carbon substitutions and a and b are 0 or 1, provided that a and b are always 0 when A.sub.1 is a desamino residue; A.sub.1 and A.sub.4 are selected from a group consisting of histidyl, arginyl, lysyl, .alpha.-naphthylalanyl, .beta.-naphthylalanyl, isoquinolyl, tyrosyl, tryptophyl, phenylalanyl, homologues and analogues thereof, and, with respect to A.sub.1 only the desamino forms thereof; A.sub.2 and A.sub.5 are selected from a group consisting of D-histidyl, D-arginyl, D-lysyl, D-.alpha.-naphthylalanyl, D-.beta.-naphthylalanyl, D-isoquinolyl, D-tyrosyl, D-tryptophyl, D-phenylalanyl, homologues and analogues thereof; A.sub.

Abstract: Pentapeptides which act directly on the pituitary to release growth hormone therefrom.

Abstract: Novel pentapeptides having the following amino acid sequenceX--Y--Z--E--G--J--Lwherein X is selected from a group consisting of --NH.sub.2, --NHCH.sub.3, and --N(CH.sub.3).sub.2 ; Y and G are independently selected from a group consisting of tyrosine, tryptophan, and phenylalanine; Z is selected from a group consisting of D-tyrosine, D-tryptophan, and D-phenylalanine; E is selected from a group consisting of glycine, alanine, valine, leucine, methionine, and isoleucine; J is selected from a group consisting of glycine, alanine, D-alanine, valine, D-valine, leucine, D-leucine, isoleucine, D-isoleucine, proline, D-proline, hydroxyproline, D-hydroxyproline, serine, D-serine, threonine, D-threonine, cysteine, D-cysteine, methionine, and D-methionine; and L is a C-terminal functional group selected from a group consisting of amide, amide lower alkyl, amide di(lower alkyl), lower alkoxy, hydroxy, and carboxy and the lower ester derivatives thereof; and the pharmaceutically acceptable salts thereof.

Abstract: Novel tripeptides having the following amino acid sequenceX-Y-Z-E-Gwherein X is selected from a group consisting of --NH.sub.2, --NHCH.sub.3, and --N(CH.sub.3).sub.2 ; Y and Z are independently selected from a group consisting of D-tyrosine, D-tryptophan, and D-phenylalanine; E is selected from a group consisting of tyrosine, tryptohan, and phenylalanine; and G is a C-terminal functional group selected froma group consisting of amide, amide lower alkyl, amide di(lower alkyl), lower alkoxy, hydroxy, and carboxy and the lower ester derivatives thereof; and the pharmaceutically acceptable salts thereof. These peptides act directly on the pituitary to release growth hormone therefrom.

Abstract: Novel pentapeptides having the following amino acid sequenceX--Y--Z--E--G--J--Lwherein X is selected from a group consisting of --NH.sub.2, --NHCH.sub.3, and --N(CH.sub.3).sub.2 ; Y and G are independently selected from a group consisting of tyrosine, tryptophan, and phenylalanine, Z and E are independently selected from a group consisting of D-tyrosine, D-tryptophan, and D-phenylalanine; J is selected from a group consisting of natural amino acids and the D-configuration thereof; and L is a C-terminal functional group selected from a group consisting of amide, amide lower alkyl, amide di(lower alkyl), lower alkoxy, hydroxy, and carboxy and the lower ester derivatives thereof; and the pharmaceutically acceptable salts thereof. These peptides act directly on the pituitary to release growth hormone therefrom.

Abstract: Novel pentapeptides having the following amino acid sequenceX-Y-Z-E-G-J-Lwherein X is selected from a group consisting of --NH.sub.2, --NHCH.sub.3, and --N(CH.sub.3).sub.2 ; Y is selected from a group consisting of tyrosine, D-tyrosine, tryptophan, D-tryptophan, phenylalanine, and D-phenylalanine; Z and E are independently selected from a group consisting of D-tyrosine, D-tryptophan, and D-phenylalanine; G is selected from a group consisting of lysine and arginine; J is selected from a group consisting of glycine, alanine, valine, leucine, isoleucine, proline, hydroxyproline, serine, threonine, cysteine, and methionine; and L is a C-terminal functional group selected from a group consisting of amide, amide lower alkyl, amide di(lower alkyl), lower alkoxy, hydroxy, and carboxy and the lower ester derivatives thereof; and the pharmaceutically acceptable salts thereof. These peptides act directly on the pituitary to release growth hormone therefrom.

Abstract: Novel pentapeptides having the following amino acid sequenceX-Y-Z-E-G-J-Lwherein X is selected from a group consisting of --NH.sub.2, --NHCH.sub.3, and --N(CH.sub.3).sub.2 ; Y and G are independently selected from a group consisting of tyrosine, trytophan, and phenlalanine; Z and J are independently selected from a group consisting of D-tyrosine, D-tryptophan, an D-phenylalanine; E is selected from a group consisting of glycine, alanine, valine, leucine, isoleucine, proline, hydroxyproline, serine, threonine, cysteine, methionine, aspartic acid, glutamic acid, asparagine, glutamine, and histidine; and L is a C-terminal functional group selected from a group consisting of amide, amide lower alkyl, amide di(lower alkyl), lower alkoxy, hydroxy, and carboxy and the lower ester derivatives thereof; and the pharmaceutically acceptable salts thereof. These peptides act directly on the pituitary to release growth hormone therefrom.

Abstract: Novel pentapeptides having the following amino acid sequenceX-Y-Z-E-G-J-Lwherein X is selected from a group consisting of --NH.sub.2, --NHCH.sub.3, and --N(CH.sub.3).sub.2 ; Y and E are independently selected from a group consisting of D-tyrosine, D-tryptophan, and D-phenylalanine; Z and G are independently selected from a group consisting of tyrosine, tryptophan, and phenylalanine; J is selected from a group consisting of glycine, alanine, valine, leucine, isoleucine, proline, hydroxyproline, serine, threonine, cysteine, methionine, aspartic acid, glutamic acid, asparagine, glutamine, arginine, and lysine; and L is a C-terminal functional group selected from a group consisting of amide, amide lower alkyl, amide di(lower alkyl), lower alkoxy, hydroxy, and carboxy and the lower ester derivatives thereof; and the pharmaceutically acceptable salts thereof. These peptides act directly on the pituitary to release growth hormone therefrom.

Abstract: Novel tetrapeptides having the following amino acid sequenceX--Y--Z--E--G--Jwherein X is selected from a group consisting of --NH.sub.2, --NHCH.sub.3, and --N(CH.sub.3).sub.2 ; Y and G are independently selected from a group consisting of tyrosine, tryptophan, and phenylalanine; Z and E are independently selected from a group consisting of D-tyrosine, D-tryptophan, and D-phenylalanine; and J is a C-terminal functional group selected from a group consisting of amide, amide lower alkyl, amide di(lower alkyl), lower alkoxy, hydroxy, and carboxy and the lower ester derivatives thereof; and the pharmaceutically acceptable salts thereof. These peptides act directly on the pituitary to release growth hormone therefrom.

Abstract: Novel pentapeptides having the following amino acid sequenceX--Y--Z--E--G--J--Lwherein X is selected from a group consisting of --NH.sub.2, --NHCH.sub.3, and --N(CH.sub.3).sub.2 ; wherein Y and G are independently selected from a group consisting of tyrosine, tryptophan, and phenylalanine; Z is selected from a group consisting of glycine, alanine, valine, leucine, isoleucine, proline, hydroxyproline, serine, threonine, cysteine, and methionine; E and J are independently selected from a group consisting of D-tyrosine, D-tryptophan, and D-phenylalanine; and L is a C-terminal functional group selected from a group consisting of amide, amide lower alkyl, amide di(lower alkyl), lower alkoxy, hydroxy, and carboxy and the lower ester derivatives thereof; and the pharmaceutically acceptable salts thereof. These peptides act directly on the pituitary to release growth hormone therefrom.

Abstract: Novel pentapeptides having the following amino acid sequenceX--Y--Z--E--G--J--Lwherein X is selected from a group consisting of --NH.sub.2, --NHCH.sub.3, and --N(CH.sub.3).sub.2 ; Y is selected from a group consisting of D-lysine and D-arginine; Z and J are independently selected from a group consisting of tyrosine, tryptophan, and phenylalanine; E and G are independently selected from a group consisting of D-tyrosine, D-tryptophan, and D-phenylalanine; and L is a C-terminal functional group selected from a group consisting of amide, amide lower alkyl, amide di(lower alkyl), lower alkoxy, hydroxy, and carboxy and the lower ester derivatives thereof; and the pharmaceutically acceptable salts thereof. These peptides act directly on the pituitary to release growth hormone therefrom.